DDA Raid Reveals Rampant Unprescribed Antibiotic Sales Across Kathmandu Valley Pharmacies
A surprise regulatory audit conducted by the Department of Drug Administration (DDA) has exposed a alarming public health violation across the Kathmandu Valley: community pharmacies are routinely dispensing powerful antibiotics without mandatory medical prescriptions.
During a targeted inspection in Lalitpur, DDA inspectors found that 13 out of 16 surveyed pharmacies readily sold Azithromycin—a potent broad-spectrum antibiotic—merely upon verbal request, bypassing all legal and ethical medical protocols.
Undercover Audit: 81% of Inspected Pharmacies Flouted Rules
To test compliance, DDA officials deployed undercover staff to request antibiotics without a doctor’s prescription. Out of the 16 establishments checked across the Satdobato and Mahalaxmi sectors—including notable outlets such as Nabin Pharmacy, Ambika Pharmacy, Easy Pharmacy, Vertex Pharmacy, and Biswas Pharmacy—13 dispensed the medication without verification. Only a minority of stores, including Gosaikunda Pharmacy and Santoshi Pharmacy, refused the unverified request.
DDA Drug Administrator Shambhu Shah expressed grave concern over the findings: “If this is the state of regulatory compliance in well-resourced areas of the capital, the situation outside the Valley must be far more severe. This indicates a widespread, systemic failure in prescription monitoring nationwide.”
The Looming Threat of “Superbugs” and Antibiotic Resistance
Medical professionals and health ministries have repeatedly warned that the unmitigated, over-the-counter misuse of antibiotics poses an existential threat to modern medicine.
- Microbial Resistance: Indiscriminate consumption trains pathogenic bacteria to mutate and develop resistance against standard pharmacological treatments.
- The Rise of Superbugs: Patients risk developing absolute drug immunity, rendering common infections untreatable and significantly elevating mortality rates.
Regulatory Loopholes and Proposed Legal Reforms
Under the current legal framework governed by the Drug Act of 1935 (2035 BS), punitive measures against non-compliant pharmacies are remarkably weak, typically restricted to mild warnings or temporary administrative suspensions.
Recognizing these legislative shortcomings, the DDA has drafted the New Drug and Health Materials Act (2083 BS) and submitted it to the Ministry of Health. The updated bill proposes severe criminal penalties, hefty fines, and permanent license cancellations for operators caught illegally dispensing controlled medications. In the interim, operators caught in the Lalitpur raid have been summoned to the department for formal disciplinary proceedings.

